Pharmacologic treatments for covid-19 patients
Favipiravir+interferon beta-1b vs Hydroxychloroquine
This comparison will not be updated. Last search date 28 Feb, 2022.
Hospitalized patients
Forest plots
(last update: 2020-12-28)
To access all information :
- click here for Hospitalized patients
You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.
Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=145
Back to your research
| Trial | Funding | Comparisons | Design | Participants | Sample size | Overall risk of bias Highest assessment |
Full description | |
|---|---|---|---|---|---|---|---|---|
| Treatment 1 | Treatment 2 | |||||||
| N/A Khamis F, Int J Infect Dis, 2020 Full text Commentary |
Private |
Favipiravir+Interferon beta-1b |
Hydroxychloroquine |
RCT | Patients with confirmed COVID-19 (moderate-severe) treated at a single center in Oman | N=89 |
Some concerns Details |
|